Tenex Health Appoints Alan Matsumoto, MD to Medical Advisory Board

LAKE FOREST, Calif., Oct. 2, 2014 (GLOBE NEWSWIRE) -- Tenex Health Inc. announced today that the internationally recognized interventional radiologist, Alan Matsumoto MD, has joined the company's Medical Advisory Board.

Dr. Matsumoto is currently a Professor of Radiology and Chair of the Department of Radiology at the University of Virginia. He has pioneered many noteworthy and innovative, minimally invasive, image-guided procedures during his 20 years at the University of Virginia. A number of these procedures have been incorporated into practice at nationally recognized medical facilities around the world. He has published more than 180 articles and book chapters and has trained more than 100 Residents and Fellows. His patient-oriented, multidisciplinary collaboration with other medical specialists has led to optimization of care in patients with complex diseases.

"Tenex Health has assembled a first-class team of medical, engineering, and business leaders, all of whom are driven to bring this compelling and innovative technology to broader use in treating chronic tendon disease," said Dr. Matsumoto. "I am pleased to join the exceptional medical advisory board and am eager to help bring this innovative technology to a broader group of physicians."

"Dr. Matsumoto is a highly respected and influential figure in radiology and image guided procedures," said Jagi Gill, founder of Tenex Health. "We are very honored to have him join our medical advisory board, and look forward to his guidance as we expand our physician customer base."

Alan Matsumoto joins a strong Tenex Health medical advisory board dedicated to ensuring the company remains on the forefront of minimally invasive technology to reduce or eliminate patient pain and suffering.

About Tenex Health, Inc.

Tenex Health, Inc. (www.tenexhealth.com) (www.tenexhealthpatient.com), develops and markets innovative therapies for the treatment of joint pain in tendon or plantar fascia tissue caused by Chronic Tendon Disease. The company's minimally invasive technology is designed to specifically cut and remove the damaged tissue in a targeted manner with the use of ultrasound image guidance. The entire procedure is completed in an outpatient setting within 20 minutes using only a local anesthetic. The precision of removing only the damaged tissue allows patients to enjoy quick recovery times without additional treatments or physical therapy.

CONTACT: Tenex Health, Inc. MaryAnn Tingley Vice-President of Marketing 949-238-8105

Source:Tenex Health